CALGARY, Canada – February 13, 2007 – SemBioSys Genetics Inc. (TSX:SBS) today announced, in connection with its previously announced public offering, that it has entered into an underwriting agreement with a syndicate led by Raymond James Ltd. and with certain of the Company’s shareholders for a total of 7,000,000 of the Company’s common shares at a price of $3.00 per share. Pursuant to the underwriting agreement, the Company expects to issue 4,251,496 of its common shares at a price of $3.00 per share (the “Primary Offering”) for total gross proceeds to SemBioSys of approximately $12,750,000. In connection with the offering, certain shareholders of the Company expect to sell 2,748,504 previously issued common shares of the Company at a price of $3.00 per share (the “Secondary Offering”).
